celica
expand biomedical research
Turning medical problems into measurable answers
Since 2000 at Ljubljana Technology Park we measure single-cell physiology, build electrophysiology instruments, and develop cell products for oncology and neurology.
01 / 03
How we work
Expertise
A research centre with work in neuroscience and oncology, and partners including UL MF, ARIS, and international programmes.
02Research
Confocal and super-resolution microscopy, electrophysiology, and cytosolic calcium, cAMP, glucose and lactate assays at the single-cell level.
03Development
HybriCure® for cell immunotherapy, SmartCure® Glia for neuroprotection, and in-house measurement instruments.
Laboratory
From the lab
Fluorescence recordings and the instruments we use daily.
Measurement quality
Measurement quality
Our laboratories run a quality management system aligned with SIST EN ISO/IEC 17025:2017. For advanced microscopy we hold accreditation LK-024 (since 13 Nov 2008) from Slovenian Accreditation (ILAC-MRA).
IMMUNOCLUSTER-2
Celica leads the Interreg Italy–Slovenia IMMUNOCLUSTER-2 project, co-funded by the EU. The aim is to start a clinical trial of a cell-based vaccine (aHyC) for triple-negative breast cancer (TNBC) across the border region.
